[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359774-105":59,"doc-detail-359774-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","vhl-synthetic-lethality-screens-uncover-cbf-as-a-negative-regulator-of-sting","VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING","","Genome-wide CRISPR/Cas9 screening identifies synthetic lethal interactors of the VHL tumor suppressor in clear cell renal cell carcinoma (ccRCC). Loss of Core Binding Factor β (CBF-β) induces cell death in VHL-null ccRCC cell lines and suppresses tumor establishment and growth in vivo. This synthetic relationship is independent of elevated hypoxia inducible factor (HIF) activity, but involves RUNX transcription factors, CBF-β’s known binding partners. Mechanistically, CBF-β loss upregulates type I interferon signaling by directly inhibiting the STING locus and Interferon Stimulated Gene expression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vhl-synthetic-lethality-screens-uncover-cbf-as-a-negative-regulator-of-sting/359774/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vhl-synthetic-lethality-screens-uncover-cbf-as-a-negative-regulator-of-sting/359774.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn Holloway","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What approach was used to study VHL-related synthetic lethality?","Question",{"text":113,"@type":114},"The study uses pooled genome-wide CRISPR/Cas9 mutagenesis in ccRCC cell lines to reveal synthetic lethal interactors of VHL.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does CBF-β loss affect VHL-null ccRCC?",{"text":118,"@type":114},"CBF-β loss selectively decreases tumor growth by causing cell death in VHL-null ccRCC cell lines and impairing tumor establishment and growth in vivo.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism links CBF-β to STING and interferon signaling?",{"text":122,"@type":114},"CBF-β loss increases type I interferon signaling by de-repressing STING transcription, leading to elevated Interferon Stimulated Gene (ISG) expression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359774,1790176679,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article [https://doi.org/10.1038/s41467-026-70517-w](https://doi.org/10.1038/s41467-026-70517-w)  \nVHL synthetic lethality screens uncover CBF-β as a negative regulator of STING  \nReceived: 19 August 2024  \n\n| Accepted: 27 February 2026 |\n| --- |\n| |\n| Check for updates |\n\nJames A. C. Bertlin 1, Tekle Pauzaite1, Qian Liang2, Niek Wit 1,  \nJames C. Williamson 1, Jia Jhing Sia 1, Nicholas J. Matheson 1,3,  \nBrian M. Ortmann1,4, Thomas J. Mitchell5, AnnelieseO. Speak 1, QingZhang 2 & James A. Nathan 1   \nClear cell renal cell carcinoma (ccRCC) represents the most common form of kidney cancer and is typiﬁed by biallelic inactivation of the von Hippel-Lindau ( VHL) tumour suppressor gene. Here, we undertake genome-wide CRISPR/ Cas9 screening to reveal synthetic lethal interactors of VHL, and uncover that loss of Core Binding Factor β (CBF-β) causes cell death in VHL-null ccRCC cell lines and impairs tumour establishment and growth in vivo. This synthetic relationship is independent of the elevated activity of hypoxia inducible factors (HIFs) in VHL-null cells, but does involve the RUNX transcription factors that are known binding partners ofCBF-β. Mechanistically, CBF-β loss leads to upregulation of type I interferon signalling, and we uncover a direct inhibitory role for CBF-β at the STING locus controlling Interferon Stimulated Gene expression. Targeting CBF-β in kidney cancer both selectively induces tumour cell lethality and promotes activation of type I interferon signalling.  \nKidney cancer is a major and growing cause of morbidity and mortality worldwide, with ~180,000 patients dying each year from the disease1,2. Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype in adults, accounting for~85%of cases3,4. While low-grade tumours can be cured by partial or radical nephrectomy, the systemic medical options to manage metastatic ccRCC remain largely inadequate, and only 13% of patients with metastatic spread at the time of diagnosis survive 5 years5.  \nBiallelic inactivation of the VHL tumour suppressor gene at chromosome 3p25 is a hallmark event in the development of ccRCC tumours6,7. Loss-of-heterozygosity of chromosome 3p occurs in childhood or adolescence, followed decades later by mutation or epigenetic inactivation of the remaining VHL allele. The subsequent acquisition of subclonal driver mutations, including of the chromatin regulators PBRM1, SETD2 and BAP1, culminates in the establishment of overt ccRCC tumours8–10. Inherited VHL mutations also underlie the hereditary autosomal dominant von Hippel-Lindau disease, in which patients develop numerous neoplasms early in life11.  \nVHL forms the substrate recognition component of the E3 ligase complex responsible for the ubiquitylation of prolyl-hydroxylated hypoxia inducible factor (HIF)-α subunits under conditions of abundant molecular oxygen12,13. In hypoxic environments, or upon genetic depletion of VHL, HIF-α accumulates, heterodimerises with HIF-1β/ ARNT, and translocates to the nucleus, whereupon it drives a diverse transcriptional program, including genes implicated in angiogenesis and glycolytic metabolism14. The stabilisation ofthe HIF-2α isoform in particular accounts for many of the distinctive features of ccRCCs: vascular endothelial growth factor (VEGF) secretion results in highly angiogenic tumours, while increased fatty acid biosynthesis and impaired mitochondrial fatty acid transport cause cytoplasmic lipid deposition and the characteristic clear cell morphology15–18.  \nThe term ‘synthetic lethality’ is used to describe the phenomenon in which the perturbation of two individually non-essential genes is lethal to a cell19. This paradigm has been used to target tumours with characteristic mutational drivers, exempliﬁed by the employment of PARP inhibitors in the treatment of BRCA1/2-defective breast and  \n1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medi","cbCaib6862UVjYPe","https://ap.wps.com/l/cbCaib6862UVjYPe","pdf",3042274,"English","# Background\n# Synthetic lethality screening strategy\n# Key findings: CBF-β loss phenotype\n# Mechanism: STING and type I interferon signaling","[{\"question\":\"What approach was used to study VHL-related synthetic lethality?\",\"answer\":\"The study uses pooled genome-wide CRISPR/Cas9 mutagenesis in ccRCC cell lines to reveal synthetic lethal interactors of VHL.\"},{\"question\":\"How does CBF-β loss affect VHL-null ccRCC?\",\"answer\":\"CBF-β loss selectively decreases tumor growth by causing cell death in VHL-null ccRCC cell lines and impairing tumor establishment and growth in vivo.\"},{\"question\":\"What mechanism links CBF-β to STING and interferon signaling?\",\"answer\":\"CBF-β loss increases type I interferon signaling by de-repressing STING transcription, leading to elevated Interferon Stimulated Gene (ISG) expression.\"}]","VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING | PDF",1790137773,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4386e421c89af45f8cc66fa528d3126.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b67bc982654b931c6af464f7150fdb7e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/967fb98b4c883fd4db3aa151dff8010c.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d39bc17339ee7090eb2593716f42ae78.webp",980,1301]